Association Between Serum Haptoglobin and Carotid Arterial Functions: Usefulness of a Targeted Metabolomics Approach
Overview
Endocrinology
Authors
Affiliations
Background: Serum haptoglobin (Hp) has been closely associated with cardio-cerebrovascular diseases. We investigated a metabolic profile associated with circulating Hp and carotid arterial functions via a targeted metabolomics approach to provide insight into potential mechanisms.
Methods: A total of 240 participants, including 120 patients with type 2 diabetes mellitus (T2DM) and 120 non-diabetes mellitus (non-DM) subjects were recruited in this study. Targeted metabolic profiles of serum metabolites were determined using an AbsoluteIDQ™ p180 Kit (BIOCRATES Life Sciences AG, Innsbruck, Austria). Ultrasound of the bilateral common carotid artery was used to measure intima-media thickness and inter-adventitial diameter. Serum Hp levels were tested by enzyme-linked immunosorbent assay.
Results: Serum Hp levels in T2DM patients and non-DM subjects were 103.40 (72.46, 131.99) mg/dL and 100.20 (53.99, 140.66) mg/dL, respectively. Significant differences of 19 metabolites and 17 metabolites were found among serum Hp tertiles in T2DM patients and non-DM subjects, respectively (P < 0.05). Of these, phosphatidylcholine acyl-alkyl C32:2 (PC ae C32:2) was the common metabolite observed in two populations, which was associated with the serum Hp groups and lipid traits (P < 0.05). Furthermore, the metabolite ratios of two acidic amino acids, including aspartate to PC ae C32:2 (Asp/PC ae C32:2) and glutamate to PC ae C32:2 (Glu/PC ae C32:2) were correlated with serum Hp, carotid arterial functions and other biochemical index in both populations significantly (P < 0.05).
Conclusions: Targeted metabolomics analyses might provide a new insight into the potential mechanisms underlying the association between serum Hp and carotid arterial functions.
Mashaba R, Phoswa W, Maimela E, Lebelo S, Modjadji P, Mokgalaboni K BMJ Open. 2024; 14(11):e087496.
PMID: 39521468 PMC: 11552583. DOI: 10.1136/bmjopen-2024-087496.
Farashi S, Bonelli R, Jackson V, Ansell B, Guymer R, Bahlo M Ophthalmol Sci. 2024; 4(5):100535.
PMID: 39091897 PMC: 11292535. DOI: 10.1016/j.xops.2024.100535.
Wang S, Deng Z, Zhang H, Zhang R, Yan D, Zheng X Cardiovasc Diabetol. 2022; 21(1):265.
PMID: 36461077 PMC: 9716717. DOI: 10.1186/s12933-022-01702-6.
Gong W, Yang S, Zhang F, Tian F, Chen J, Yin Z J Nanobiotechnology. 2021; 19(1):272.
PMID: 34496877 PMC: 8425071. DOI: 10.1186/s12951-021-01020-1.